Release test results
99.553%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.03 mg
Related impurities (total)0.447%
Endotoxin<1.0 EU/mg
HPLC retention time6.56 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundSemax
Presentation10 MG
Lot numberRGX-26-RGNX-750
COA numberNS-2026-05175
Test date30 Mar 2026
Release date02 Apr 2026
Independent labNordicstar Labs
StatusSuperseded
Semax — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGNX-1049 | 5 MG | Jul 14, 2026 | 99.599% | Current |
| RGX-26-RGNX-1050 | 10 MG | Jul 14, 2026 | 99.561% | Current |
| RGX-26-RGNX-750 this lot | 10 MG | Mar 30, 2026 | 99.553% | Superseded |
| RGX-26-RGNX-751 | 5 MG | Mar 28, 2026 | 99.629% | Superseded |
| RGX-26-RGNX-650 | 10 MG | Jan 2, 2026 | 99.660% | Superseded |
| RGX-25-RGNX-651 | 5 MG | Dec 31, 2025 | 99.736% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →